Physician profile
Sharon Powers
NPI 1447691456
$6,204.12
in general payments reported to CMS, 2019-2025
44 companies · $1,587 in 2025
The $1,587 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,035 · 2022: $821 · 2023: $1,032 · 2024: $1,729 · 2025: $1,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,348.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $971.06 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $906.38 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $773.77 | 2022-2025 | |
| Glaxosmithkline, LLC. | $452.44 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $404.33 | 2023-2025 | |
| Amgen INC. | $340.03 | 2023-2025 | Repatha, Otezla, Repatha |
| Abbott Laboratories | $243.11 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $226.30 | 2021-2024 | Mounjaro, Emgality, Jardiance |
| Exact Sciences Corporation | $201.06 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.04 | 2021-2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.97 | 2021-2025 | Jardiance, Synjardy |
| Amarin Pharma, INC. | $137.86 | 2021-2022 | |
| Corium, LLC | $136.69 | 2024-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $94.20 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Astellas Pharma US INC | $90.08 | 2021-2025 | Veozah |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.